Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol
Date Issued
2022-01-01
Author(s)
Peacock, W. Frank
Maisel, Alan S.
Anker, Stefan D.
Apple, Fred S.
Christenson, Robert H.
Collinson, Paul
Daniels, Lori B.
Diercks, Deborah B.
Somma, Salvatore Di
Filippatos, Gerasimos
Headden, Gary
Hiestand, Brian
Hollander, Judd E.
Kaski, Juan C.
Kosowsky, Joshua M.
Nagurney, John T.
Nowak, Richard M.
Schreiber, Donald
Vilke, Gary M.
Wayne, Marvin A.
Than, Martin
DOI
10.15441/ceem.21.154
Abstract
To determine the utility of a highly sensitive troponin assay when utilized in the emergency department.; The FAST-TRAC study prospectively enrolled >1,500 emergency department patients with suspected acute coronary syndrome within 6 hours of symptom onset and 2 hours of emergency department presentation. It has several unique features that are not found in the majority of studies evaluating troponin. These include a very early presenting population in whom prospective data collection of risk score parameters and the physician's clinical impression of the probability of acute coronary syndrome before any troponin data were available. Furthermore, two gold standard diagnostic definitions were determined by a pair of cardiologists reviewing two separate data sets; one that included all local troponin testing results and a second that excluded troponin testing so that diagnosis was based solely on clinical grounds. By this method, a statistically valid head-to-head comparison of contemporary and high sensitivity troponin testing is obtainable. Finally, because of a significant delay in sample processing, a unique ability to define the molecular stability of various troponin assays is possible.; ClinicalTrials.gov Identifier NCT00880802.
File(s)![Thumbnail Image]()
Loading...
Name
ceem-21-154.pdf
Size
95.19 KB
Format
Adobe PDF
Checksum
(MD5):02e524ac6e7f7b5792e169a23cf8e61e